RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
NANO MRNA Co Stock

NANO MRNA Co P/S 2024

NANO MRNA Co P/S

90.26

Ticker

4571.T

ISIN

JP3651120002

WKN

A0NCX4

As of Sep 10, 2024, NANO MRNA Co's P/S ratio stood at 90.26, a 13.69% change from the 79.39 P/S ratio recorded in the previous year.

The NANO MRNA Co P/S history

NANO MRNA Co Aktienanalyse

What does NANO MRNA Co do?

NANO MRNA Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding NANO MRNA Co's P/S Ratio

NANO MRNA Co's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing NANO MRNA Co's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating NANO MRNA Co's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in NANO MRNA Co’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about NANO MRNA Co stock

What is the price-to-earnings ratio of NANO MRNA Co?

The price-earnings ratio of NANO MRNA Co is currently 90.26.

How has the price-earnings ratio of NANO MRNA Co changed compared to last year?

The price-to-earnings ratio of NANO MRNA Co has increased by 13.69% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of NANO MRNA Co high compared to other companies?

Yes, the price-to-earnings ratio of NANO MRNA Co is high compared to other companies.

How does an increase in the price-earnings ratio of NANO MRNA Co affect the company?

An increase in the price-earnings ratio of NANO MRNA Co would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of NANO MRNA Co affect the company?

A decrease in the price-earnings ratio of NANO MRNA Co would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of NANO MRNA Co?

Some factors that influence the price-earnings ratio of NANO MRNA Co are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does NANO MRNA Co pay?

Over the past 12 months, NANO MRNA Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, NANO MRNA Co is expected to pay a dividend of 0 JPY.

What is the dividend yield of NANO MRNA Co?

The current dividend yield of NANO MRNA Co is .

When does NANO MRNA Co pay dividends?

NANO MRNA Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of NANO MRNA Co?

NANO MRNA Co paid dividends every year for the past 0 years.

What is the dividend of NANO MRNA Co?

For the upcoming 12 months, dividends amounting to 0 JPY are expected. This corresponds to a dividend yield of 0 %.

In which sector is NANO MRNA Co located?

NANO MRNA Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von NANO MRNA Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of NANO MRNA Co from 9/10/2024 amounting to 0 JPY, you needed to have the stock in your portfolio before the ex-date on 9/10/2024.

When did NANO MRNA Co pay the last dividend?

The last dividend was paid out on 9/10/2024.

What was the dividend of NANO MRNA Co in the year 2023?

In the year 2023, NANO MRNA Co distributed 0 JPY as dividends.

In which currency does NANO MRNA Co pay out the dividend?

The dividends of NANO MRNA Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von NANO MRNA Co

Our stock analysis for NANO MRNA Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of NANO MRNA Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.